PHF20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.691600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.403000E-01
Normal-vs-Stage2
3.118200E-01
Normal-vs-Stage3
1.406150E-01
Normal-vs-Stage4
8.307600E-01
Stage1-vs-Stage2
5.868400E-01
Stage1-vs-Stage3
1.413800E-01
Stage1-vs-Stage4
3.698500E-02
Stage2-vs-Stage3
1.256000E-01
Stage2-vs-Stage4
1.207770E-01
Stage3-vs-Stage4
2.170100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.643000E-01
Normal-vs-AfricanAmerican
6.583200E-01
Normal-vs-Asian
1.450200E-01
Caucasian-vs-AfricanAmerican
5.151400E-01
Caucasian-vs-Asian
2.866200E-01
AfricanAmerican-vs-Asian
2.126000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.617600E-01
Normal-vs-Female
3.095200E-01
Male-vs-Female
6.060600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.781200E-01
Normal-vs-Age(41-60Yrs)
6.427400E-01
Normal-vs-Age(61-80Yrs)
1.777420E-01
Normal-vs-Age(81-100Yrs)
1.725020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.308600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.827200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.817800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.555580E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.684300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.755000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.096600E-01
Normal-vs-Daily Drinker
1.493980E-01
Normal-vs-Weekly Drinker
3.894800E-01
Normal-vs-Occasional Drinker
5.074400E-01
Normal-vs-Social Drinker
4.772800E-01
Non Drinker-vs-Daily Drinker
9.297000E-01
Non Drinker-vs-Weekly Drinker
3.933600E-01
Non Drinker-vs-Occasional Drinker
1.969630E-01
Non Drinker-vs-Social Drinker
2.484800E-01
Daily Drinker-vs-Weekly Drinker
3.212800E-01
Daily Drinker-vs-Occasional Drinker
1.559620E-01
Daily Drinker-vs-Social Drinker
1.932980E-01
Weekly Drinker-vs-Occasional Drinker
7.254000E-01
Weekly Drinker-vs-Social Drinker
7.850800E-01
Occasional Drinker-vs-Social Drinker
9.392200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.872200E-01
Normal-vs-Grade 2
8.806000E-01
Normal-vs-Grade 3
8.824000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.467420E-01
Grade 1-vs-Grade 3
1.755950E-01
Grade 1-vs-Grade 4
9.872200E-01
Grade 2-vs-Grade 3
9.740200E-01
Grade 2-vs-Grade 4
8.806000E-01
Grade 3-vs-Grade 4
8.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.858570E-01
Normal-vs-NonDiabetic
2.304400E-01
Diabetic-vs-NonDiabetic
6.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.305000E-01
Normal-vs-NoPancreatitis
2.444400E-01
Pancreatitis-vs-NoPancreatitis
8.883600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.835200E-01
Normal-vs-N1
3.371200E-01
N0-vs-N1
3.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.271000E-01
Normal-vs-TP53-NonMutant
2.177000E-01
TP53-Mutant-vs-TP53-NonMutant
2.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
